CINCINNATI — Prasco Labs has contracted to sell an authorized generic version of a painkiller made by Shionogi, Prasco said Monday.
Under the agreement between the two companies, Prasco will market and distribute an authorized generic version of Ponstel (mefenamic acid) capsules in the 250-mg strength.
“With the introduction of the authorized generic of Shionogi’s Ponstel, Prasco continues to be the preferred partner for established brand companies to transcend their brands with our authorized generics,” Prasco CEO E. Thomas Arington said. “We are pleased to have established this relationship with Shionogi Inc., a company that has been providing innovative medicines essential to people’s health.”
Authorized generics are branded drugs sold under their generic names, usually as part of an agreement by a branded drug maker and a third-party company.